Intravenous Route to Choroidal Neovascularization by Macrophage-Disguised Nanocarriers for Mtor Modulation
Weiyi Xia,Chao Li,Qinjun Chen,Jiancheng Huang,Zhenhao Zhao,Peixin Liu,Kai Xu,Lei Li,Fangyuan Hu,Shujie Zhang,Tao Sun,Chen Jiang,Chen Zhao
DOI: https://doi.org/10.1016/j.apsb.2021.10.022
IF: 14.903
2022-01-01
Acta Pharmaceutica Sinica B
Abstract:Retinal pigment epithelial(RPE)is primarily impaired in age-related macular degeneration(AMD),leading to progressive loss of photoreceptors and sometimes choroidal neovascularization(CNV).mTOR has been proposed as a promising therapeutic target,while the usage of its specific inhibitor,rapamycin,was greatly limited.To mediate the mTOR pathway in the retina by a noninvasive approach,we developed novel biomimetic nanocomplexes where rapamycin-loaded nanoparticles were coated with cell membrane derived from macrophages(termed as MRaNPs).Taking advantage of the macrophage-inherited property,intravenous injection of MRaNPs exhibited significantly enhanced accumulation in the CNV le-sions,thereby increasing the local concentration of rapamycin.Consequently,MRaNPs effectively down-regulated the mTOR pathway and attenuate angiogenesis in the eye.Particularly,MRaNPs also efficiently activated autophagy in the RPE,which was acknowledged to rescue RPE in response to delete-rious stimuli.Overall,we design and prepare macrophage-disguised rapamycin nanocarriers and demon-strate the therapeutic advantages of employing biomimetic cell membrane materials for treatment of AMD.